Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.
about
Recent advances in understanding and management of acquired thrombocytopenia.Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis.Eltrombopag-based combination treatment for immune thrombocytopeniaSuccessful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopagActivity of eltrombopag in severe aplastic anemia
P2860
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Safety and efficacy of long-te ...... l results of the EXTEND study.
@en
Safety and efficacy of long-te ...... l results of the EXTEND study.
@nl
type
label
Safety and efficacy of long-te ...... l results of the EXTEND study.
@en
Safety and efficacy of long-te ...... l results of the EXTEND study.
@nl
prefLabel
Safety and efficacy of long-te ...... l results of the EXTEND study.
@en
Safety and efficacy of long-te ...... l results of the EXTEND study.
@nl
P2093
P1433
P1476
Safety and efficacy of long-te ...... l results of the EXTEND study.
@en
P2093
Abderrahim Khelif
Abdulgabar Salama
Mansoor N Saleh
Maria Socorro O Portella
Paul Burgess
Raymond S M Wong
P304
P356
10.1182/BLOOD-2017-04-748707
P407
P577
2017-10-17T00:00:00Z